• About us
• Contact

Advertisement

Organisation › Details

Takeda (Group)

Located in Osaka, Japan, Takeda is a research based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for patients worldwide through leading innovation in medicine. *

 

	Start	1990-01-01 existent
	Industry	pharmaceutical
	Person	Weber, Christophe (Takeda 201504– CEO joined as COO 4/14 before GSK 201305 President GSK Vaccines)
	Street	1-1 Doshomachi 4-chome Chuo-ku
	City	540-8645 Osaka
	Tel	+81-6-6204-2111
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2022-03-31)
	Currency	JPY
	Annual sales	3,569,006,000,000 (revenue, consolidated (21/22) 2022-03-31)
	Profit	230,059,000,000 (2022-03-31)
	Cash	849,695,000,000 (2022-03-31)
		* Document for »About Section«:
		Record changed: 2024-08-24

Advertisement

More documents for Takeda (Group)

• [1] AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne....
• [2] T-Curx GmbH. (8/28/23). "Press Release: T-Curx GmbH Announces Appointment of Two Industry Leaders to Its Board of Directors"....
• [3] Fresenius Medical Care AG & Co. KGaA. (12/5/22). "Press Release: Helen Giza to Take Over as Chief Executive Officer of Fresenius Medical Care"....
• [4] Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg....
• [5] Evotec SE. (3/22/21). "Press Release: Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance". Hamburg....
• [6] Evotec SE. (4/6/20). "Press Release: Evotec and Takeda Enter into Multi-year Gene Therapy Research Alliance". Hamburg....
• [7] Evotec SE. (3/26/20). "Press Release: Evotec SE Fiscal Year 2019 Results". Hamburg....
• [8] Evotec SE. (9/24/19). "Press Release: Evotec and Takeda Enter Collaboration Agreement to Discover Clinical Candidates across Multiple Therapeutic Areas". Hamburg....
• [9] Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf....
• [10] Centogene AG. (5/9/19). "Press Release: Centogene Expands Executive Leadership Team". Cambridge, MA & Rostock....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.